Large firms in the United States (US), despite incurring billions of dollars in this process, have a success rate of less than ten per cent. Especially as the regulatory environment in the US tightens and less capital is available for new biotech ventures, US biotech companies must seriously re-evaluate their approach to testing new therapeutics. While US firms may have a competitive edge in the scientific development of new therapeutics, the principal driver of costs and the most common point of failure is the real-world, clinical testing of these products. This pain point is likely to be exacerbated in the coming years due to the shift towards biologics – a type of drug made using living organisms – which are far less predictable in terms of their expected effectiveness.
Enter India. Over the last few decades, India’s aggregate population has grown and so has the diversity of prevalent diseases within the population. Its infrastructure, specifically digital infrastructure and its penetration to the individual level, has witnessed a phenomenal growth. Additionally, India’s pharmaceutical manufacturing capability has also expanded, with the country often called ‘the world’s pharmacy’. With India’s rise as a global powerhouse in healthcare and increasing domestic pressures on the US biotech industry, a US-India partnership in therapeutics development would be hugely beneficial for healthcare worldwide.
Diese Geschichte stammt aus der May 18, 2024-Ausgabe von BW Businessworld.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der May 18, 2024-Ausgabe von BW Businessworld.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
A WAVE OF PARIVARTAN
KAIZAD M. BHARUCHA on HDFC Bank's flagship CSR programme Parivartan ('Change' in Hindi), and how it has made a profound impact on the lives of over 10 crore people, embodying progress and positive transformation
An Ace In All Regards
The Sonos Ace offers an interesting proposition by clubbing peak design, respectable ANC and a decent battery life
For the love of Street Food
Feel like eating something different? How about a Slow-Cooked Grilled Belgium Pork Leg? The dish is inspired by the festive streets of Italy, Germany, and Austria, where pork takes centre stage during the winter. Cooked to perfection over 24 hours, it pairs tender pork with a sweet and spicy apple purée, salsa macha, and crunchy pork floss.
India's Most Influential Marketing Leaders
The BW Top 100 Marketers 2024 sees significant representation from sectors such as FMCG, BFSI, auto and tech as the likes of healthcare register growth; women leaders account for over 27 per cent of the list
HERALDING THE ERA OF PRIVATE
Broadcom CEO & President Hock Tan asserts that the future of enterprise IT lies in private cloud solutions
Sustainable M&A Through Double Materiality
IN THE HIGH-STAKES WORLD of mergers and acquisitions (M&A), the focus has long been on traditional synergy metrics.
Lenovo's Puducherry Tryst...Now With An AI Twist
Lenovo's APAC and India leadership, including AMAR BABU, President, Lenovo APAC, AMIT LUTHRA, Managing Director, Lenovo ISG India and SUMIR BHATIA, President, Lenovo ISG Group - APAC, spoke with BW Businessworld's Rohit Chintapali on the company's new manufacturing capabilities based out of Puducherry facility that will now involve AI servers and high-end GPU units.Excerpts
40 Under 40 - Making A Mark
Hive Minds partners with clients across various sectors to deliver strategies focused on growth, creativity and client satisfaction
40 Under 40 - Leading The Charge
Visaka's Vamsi Krishna Gaddam advocates for ecoconscious business practices, driving innovations in building materials, electric mobility, solar energy and more
40 Under 40 - Judicial Efficiency
Adalat AI leverages tech to minimise case backlogs and enhance judicial efficiency, with ambitious plans for expansion across additional courts in India